MYND Lifesciences Inc.

CSE: MYND

Company Logo

Company Overview

MYND Life Science Inc. is a leading life sciences company focussed on improving mental health. The company has confirmed access to Health Canada psilocybin research and development. Patents have been filed based on therapeutic approaches to treat diseases of the Central Nervous System using neuroactive agents including psychedelics and other compounds. Research and development is currently underway.

Financial Highlights

$0

Revenue (ttm)

$0

Gross Profit (ttm)

-$0.10

Diluted EPS (ttm)

Management Team

Dr. Wilfred A. Jefferies
Co-Founder, Chairman & Chief Science Officer

Dr. Lyle Oberg M.D.
Co-Founder, CEO & Director

Mr. Lih-Ming Tam
Interim CFO & Sr. Controller

Dr. Chaahat S.B Singh
Sr. Operations & Research Mang.

Mr. Luke Warkentin
VP of Corp. Devel.

Dr. Iryna Saranchova Ph.D.
Chief Clinical Officer

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$0

Shares Outstanding
0

Shares Short (% of Float)
()

Insider Ownership
32%